Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer | MicrobiomeTrials← Back to trialsNCT00050752
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 1,350 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Kidney NeoplasmsKidney CancerPneumothoraxFLCN Protein, Human
This study will investigate the genetic cause of Birt Hogg-Dube (BHD) syndrome and the relationship of this disorder to …
Bethesda, United States
Metastatic MelanomaAdvanced Locoregional MelanomaMetastatic Renal Cell CarcinomaClear Cell Histology
Background:
Aldesleukin is used to treat metastatic or advanced melanoma and renal cell carcinoma. Pembrolizumab is use…
Bethesda, United StatesEst. completion Sep 1, 2031